Role of topical fluoroquinolones on the pathogenesis of diffuse lamellar keratitis in experimental in vivo studies
Authors:
- 1 February 2006
- journal article
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 32 (2) , 264-268
Abstract
PURPOSE: To investigate the potential role of commercially available topical fluoroquinolones in diffuse lamellar keratitis (DLK) using New Zealand White rabbit models. SETTING: Campbell Ophthalmic Microbiology Laboratory at the University of Pittsburgh, Pittsburgh, Pennsylvania, USA. METHODS: In a DLK challenge model, laser in situ keratomileusis flaps were created by a microkeratome in rabbit eyes (n = 10 per group) and the stromal beds were treated with 1 drop of Ciloxan (ciprofloxacin 0.3%), Ocuflox (ofloxacin 0.3%), balanced salt solution (BSS), or Pseudomonas aeruginosa endotoxin before flap closure. After the procedure, eyes were treated with the same drugs 4 times daily. On postoperative day 1, the eyes were examined by slitlamp and graded (modified Linebarger DLK grading scale) in a masked fashion. In a DLK exacerbation model, all eyes received 1 drop of endotoxin on the stromal interface followed by flap closure. After the procedure, the rabbit eyes (10 per group) were treated 4 times daily with Ciloxan, Ocuflox, or BSS and graded for DLK on postoperative day 1 as before. RESULTS: In the challenge model, Ciloxan, Ocuflox, and endotoxin all produced higher median DLK scores than the BSS control (P = .02). Ciloxan produced significant DLK in more eyes and had higher median scores (70%, 1.0) than Ocuflox (40%, 0.5) or endotoxin (45%, 0.5) (P = .05). In the endotoxin-induced model, Ciloxan produced significantly higher DLK scores than Ocuflox or BSS (P = .05). CONCLUSIONS: Topical fluoroquinolones caused and exacerbated DLK in rabbit models. Ocuflox was associated with less DLK than Ciloxan. The clinical significance of these findings can only be assessed in clinical trials.Keywords
This publication has 35 references indexed in Scilit:
- The Epidemiology of Diffuse Lamellar KeratitisCornea, 2004
- The Efficacy of Hourly Prophylactic Steroids in Diffuse Lamellar Keratitis EpidemicOphthalmologica, 2004
- Evaluation of preoperative and postoperative prophylactic regimens for prevention and treatment of diffuse lamellar keratitisJournal of Cataract & Refractive Surgery, 2004
- Detection of neutrophils and possible involvement of interleukin-8 in diffuse lamellar keratitis after laser in situ keratomileusisJournal of Cataract & Refractive Surgery, 2003
- Bilateral diffuse lamellar keratitis following bilateral simultaneous versus sequential laser in situ keratomileusisBritish Journal of Ophthalmology, 2003
- Corneal flap complications in refractive surgeryJournal of Cataract & Refractive Surgery, 2003
- Diffuse lamellar keratitis: Evaluation of etiology, histopathologic findings, and clinical implications in an experimental animal modelJournal of Cataract & Refractive Surgery, 2003
- Flap complications associated with lamellar refractive surgeryAmerican Journal of Ophthalmology, 1999
- Interface inflammation after laser in situ keratomileusisJournal of Cataract & Refractive Surgery, 1998
- Diffuse lamellar keratitis A new syndrome in lamellar refractive surgeryOphthalmology, 1998